Xvivo Perfusion AB

Xvivo Perfusion AB develops, manufactures, and sells innovative solutions and devices designed to facilitate organ transplantation. Its primary aim is to enhance the viability and quality of donor organs, thereby improving outcomes for transplant recipients worldwide. Operating within the medical technology sector, Xvivo Perfusion AB specialises in advanced perfusion systems. Their approach focuses on optimising organ preservation outside the body, which intends to expand the pool of usable organs and enhance long-term patient survival rates. Keep up to date on the latest share price changes by adding XVIVO.ST stock to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.